Uncategorized – Page 6 – Jeffrey B. Simon

Marketing Kills: Origins of the Opioid Epidemic

Representing Dallas County and counties throughout Texas, we have worked to hold prescription opioid pharmaceutical manufacturers, wholesale, and distributors financially accountable for their role in causing, fueling, and profiting from the largest drug-related public health crisis in American history. Full Article Below:

TWITTER CANCELED ME FOR NO REASON AND WHY YOU SHOULD CARE

“Censorship is to art as lynching is to justice.”― Henry Louis Gates Jr, Professor, Harvard University Social media connects the world, or so we’re told. People from every walk of life everywhere utilize social media platforms to form and maintain connections with others through expressions of facts, opinions, interests, and sentiments. Platforms today like… Continue reading TWITTER CANCELED ME FOR NO REASON AND WHY YOU SHOULD CARE

Fighting the War Against Drug Addiction in the Courts

Jeffrey B. Simon sits down with The Addiction Podcast for an in-depth discussion on the opioid epidemic and how he is holding large drug manufacturers accountable. In this episode, Mr. Simon will also cover opioid litigation, his historic opioid settlements, the prescribing, marketing & diversion of controlled substances and how other states can create… Continue reading Fighting the War Against Drug Addiction in the Courts

Simon Recognized in 2022 Lawdragon 500 Leading Plaintiff Consumer Lawyers

From the opioid epidemic to toxic substances and defective products, truck accidents to wildfires and sexual abuse, these are the lawyers who stand on the front line in individual lawsuits and class actions seeking justice. They relish their role of underdog, taking on the toughest cases and typically only getting paid if they win. The… Continue reading Simon Recognized in 2022 Lawdragon 500 Leading Plaintiff Consumer Lawyers

Steps Pharmacists Can Take to Help Address the Opioid Epidemic in the Pharmacy

Pharmacy Times interviewed Jeffrey B. Simon, JD, co-chair of the National Opioid Litigation Conference and a lead negotiator for the many local districts participating in the historic settlement in a multi-district opioid lawsuit in Texas. Alana Hippensteele: What are some steps that pharmacists could take to help address the opioid epidemic in the pharmacy? Jeffrey… Continue reading Steps Pharmacists Can Take to Help Address the Opioid Epidemic in the Pharmacy

Simon Greenstone Panatier Law Firm Proud of $1.85 Billion Texas Opioid Settlement

Pharmaceutical manufacturers, distributors will reimburse state, local governments with cash and overdose medications Simon Greenstone Panatier, PC, announced today that the firm’s lead attorney in opioid litigation, Jeffrey B. Simon, working with a committee of trial lawyers and the Office of the Texas Attorney General, have reached historic settlements totaling $1.85 billion for Texans in… Continue reading Simon Greenstone Panatier Law Firm Proud of $1.85 Billion Texas Opioid Settlement

Expert: Opioid-Related Lawsuits ‘Against Retail Pharmacies Are Now Coming to the Forefront’- Part 1

Pharmacy Times interviewed Jeffrey B. Simon, JD, co-chair of the National Opioid Litigation Conference and a lead negotiator for the many local districts participating in the historic settlement in a multi-district opioid lawsuit in Texas. Jeffrey B. Simon, JD, co-chair of the National Opioid Litigation Conference, discusses the historic settlement in a multi-district opioid lawsuit… Continue reading Expert: Opioid-Related Lawsuits ‘Against Retail Pharmacies Are Now Coming to the Forefront’- Part 1

Implications of Opioid Lawsuits on Opioid Availability- Part 2

Jeffrey B. Simon, JD, co-chair of the National Opioid Litigation Conference, discusses the historic settlement in a multi-district opioid lawsuit in Texas. Pharmacy Times interviewed Jeffrey B. Simon, JD, co-chair of the National Opioid Litigation Conference and a lead negotiator for the many local districts participating in the historic settlement in a multi-district opioid lawsuit… Continue reading Implications of Opioid Lawsuits on Opioid Availability- Part 2

States Sprint Toward Deadline in $26B Opioid Deal Designed to Deliver ‘Global Peace’

Drug companies must decide by Friday whether to move forward with, or walk away from, funds that would compensate nearly all 50 states and U.S. territories for costs incurred by the opioid crisis.

Dallas County to receive $2.3 million from Johnson & Johnson in opioid settlement

Dallas County commissioners voted to accept a $2.3 million settlement Wednesday from pharmaceutical company Janssen, a subsidiary of Johnson & Johnson, over the toll of the opioid epidemic. The agreement is part of a global $26 billion settlement of thousands of lawsuits against Johnson & Johnson and three of the largest drug distributors — AmerisourceBergen,… Continue reading Dallas County to receive $2.3 million from Johnson & Johnson in opioid settlement